Literature DB >> 29793990

Proteases, Protease-Activated Receptors, and Atherosclerosis.

Wolfram Ruf1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29793990      PMCID： PMC5976259          DOI： 10.1161/ATVBAHA.118.311139

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  20 in total

1.  Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.

Authors:  Leila M Sevigny; Karyn M Austin; Ping Zhang; Shogo Kasuda; Georgios Koukos; Sheida Sharifi; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

2.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Authors:  John W Eikelboom; Stuart J Connolly; Jackie Bosch; Gilles R Dagenais; Robert G Hart; Olga Shestakovska; Rafael Diaz; Marco Alings; Eva M Lonn; Sonia S Anand; Petr Widimsky; Masatsugu Hori; Alvaro Avezum; Leopoldo S Piegas; Kelley R H Branch; Jeffrey Probstfield; Deepak L Bhatt; Jun Zhu; Yan Liang; Aldo P Maggioni; Patricio Lopez-Jaramillo; Martin O'Donnell; Ajay K Kakkar; Keith A A Fox; Alexander N Parkhomenko; Georg Ertl; Stefan Störk; Matyas Keltai; Lars Ryden; Nana Pogosova; Antonio L Dans; Fernando Lanas; Patrick J Commerford; Christian Torp-Pedersen; Tomek J Guzik; Peter B Verhamme; Dragos Vinereanu; Jae-Hyung Kim; Andrew M Tonkin; Basil S Lewis; Camilo Felix; Khalid Yusoff; P Gabriel Steg; Kaj P Metsarinne; Nancy Cook Bruns; Frank Misselwitz; Edmond Chen; Darryl Leong; Salim Yusuf
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

3.  EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.

Authors:  Hai Po H Liang; Edward J Kerschen; Irene Hernandez; Sreemanti Basu; Mark Zogg; Fady Botros; Shuang Jia; Martin J Hessner; John H Griffin; Wolfram Ruf; Hartmut Weiler
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

4.  Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo.

Authors:  Q M Nhu; K Shirey; J R Teijaro; D L Farber; S Netzel-Arnett; T M Antalis; A Fasano; S N Vogel
Journal:  Mucosal Immunol       Date:  2009-10-28       Impact factor: 7.313

5.  Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice.

Authors:  Reut Shnerb Ganor; Dror Harats; Ginette Schiby; David Gailani; Hanna Levkovitz; Camila Avivi; Ilia Tamarin; Aviv Shaish; Ophira Salomon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-21       Impact factor: 8.311

6.  Activation of cartilage matrix metalloproteinases by activated protein C.

Authors:  Miriam T Jackson; Margaret M Smith; Susan M Smith; Christopher J Jackson; Meilang Xue; Christopher B Little
Journal:  Arthritis Rheum       Date:  2009-03

7.  Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.

Authors:  Hyesook Yoon; Maja Radulovic; Jianmin Wu; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2013-05-27       Impact factor: 5.372

8.  Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation.

Authors:  Leylla Badeanlou; Christian Furlan-Freguia; Guang Yang; Wolfram Ruf; Fahumiya Samad
Journal:  Nat Med       Date:  2011-10-23       Impact factor: 53.440

9.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

Authors:  Marie-Luise von Brühl; Konstantin Stark; Alexander Steinhart; Sue Chandraratne; Ildiko Konrad; Michael Lorenz; Alexander Khandoga; Anca Tirniceriu; Raffaele Coletti; Maria Köllnberger; Robert A Byrne; Iina Laitinen; Axel Walch; Alexander Brill; Susanne Pfeiler; Davit Manukyan; Siegmund Braun; Philipp Lange; Julia Riegger; Jerry Ware; Annekathrin Eckart; Selgai Haidari; Martina Rudelius; Christian Schulz; Katrin Echtler; Volker Brinkmann; Markus Schwaiger; Klaus T Preissner; Denisa D Wagner; Nigel Mackman; Bernd Engelmann; Steffen Massberg
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

10.  PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.

Authors:  Ranjeet K Sinha; Yaoming Wang; Zhen Zhao; Xiao Xu; Laurent Burnier; Naveen Gupta; José A Fernández; Greg Martin; Sergey Kupriyanov; Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2018-01-17       Impact factor: 25.476
View more
  5 in total

1.  Protease Activity in Vascular Disease.

Authors:  Megan A Slack; Scott M Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-25       Impact factor: 8.311

Review 2.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

3.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022

Review 4.  Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives.

Authors:  Lei Wang; Chaojun Tang
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

5.  Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.

Authors:  Julian Friebel; Eileen Moritz; Marco Witkowski; Kai Jakobs; Elisabeth Strässler; Andrea Dörner; Daniel Steffens; Marianna Puccini; Stella Lammel; Rainer Glauben; Franziska Nowak; Nicolle Kränkel; Arash Haghikia; Verena Moos; Heinz-Peter Schutheiss; Stephan B Felix; Ulf Landmesser; Bernhard H Rauch; Ursula Rauch
Journal:  Cells       Date:  2021-12-13       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.